<?xml version="1.0" encoding="UTF-8"?>
<p>Our finding of benefit at three days and a smaller benefit at five days post-inoculation sets likely practical limits for when clinicians would have to initiate treatment. This narrow window of opportunity from the onset of clinical symptoms within which dual antiviral and NSAID therapy must be initiated emphasizes the role of early diagnosis.</p>
